Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3beta-Thalassemia 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Hematologic Neoplasms 2Thalassemia 1Shwachman-Diamond Syndrome 1Primary Myelofibrosis 1Neurofibromatosis 1 1Neoplasm, Residual 1Multiple Myeloma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Influenza, Human 1Hemoglobinuria, Paroxysmal 1Congenital amegakaryocytic thrombocytopenia 1Chromosome Aberrations 1Chromosome 7, monosomy 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Refractory, with Excess of Blasts 1Anemia, Hypochromic 1Anemia, Diamond-Blackfan 1

Interventions

asciminib 15Cyclophosphamide 12fludarabine phosphate 10Mycophenolic Acid 9fludarabine 8nilotinib 7Whole-Body Irradiation 7Imatinib Mesylate 6Dasatinib 6Tacrolimus 5Sirolimus 5Cyclosporine 5venetoclax 4bosutinib 4Melphalan 4Granulocyte Colony-Stimulating Factor 4ponatinib 3Thiotepa 3Stem Cell Transplantation 3Peripheral Blood Stem Cell Transplantation 3Cyclosporins 3Busulfan 3thymoglobulin 2ruxolitinib 2Specimen Handling 2Mesna 2Magnetic Resonance Spectroscopy 2Filgrastim 2Blood Component Removal 2treosulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive × thymoglobulin × 90 days × Clear all
NCT03849651 2026-06-03

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
69 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT04888741 2026-05-05

MoTD

University of Birmingham

Phase 2 Recruiting
400 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡